Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: wvalx who wrote (21097)	4/21/1999 8:06:00 PM
From: VLAD	Respond to of 23519

wvalx, I agree 100%. IMO the future for Vivus is GOOD at worst. As you said before look at the internuts. The reason AMZN is trading at $180/share (over 161 million shares outstanding and a book value of $0.87) when they expect to lose almost $1.00/share in FY 1999 is because of the perception that they are doing the right things to make some good profits looking out to the future at least 2 or 3 years. By the same token, I believe Vivus is doing the right things to secure a profitable future by 1)focusing on R&D and 2)protecting their intellectual properties with patents and 3)negotiating strategic partnerships in order to market and sell MUSE and future products.